MicroRNAs in neurodegenerative diseases and their therapeutic potential.
about
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorderssiRNA Versus miRNA as Therapeutics for Gene SilencingHIV-associated neuropathogenesis: a systems biology perspective for modeling and therapyAntisense oligonucleotides: treating neurodegeneration at the level of RNAMicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNSMiR-299-5p regulates apoptosis through autophagy in neurons and ameliorates cognitive capacity in APPswe/PS1dE9 mice.Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-ReviewParkinson's disease as a result of agingThe MAPT H1 haplotype is associated with tangle-predominant dementiaProfiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathologyWidespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers.MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA.The role of microRNAs in human neural stem cells, neuronal differentiation and subtype specificationInhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing.miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvementPhenotypic and genetic characterization of a family carrying two Xq21.1-21.3 interstitial deletions associated with syndromic hearing loss.MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death.A potential role of homeobox transcription factors in osteoarthritis.Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins.MicroRNA in Aging: From Discovery to BiologyMicroRNAs as Biomarkers in Cancer.Non-coding RNA and pseudogenes in neurodegenerative diseases: "The (un)Usual Suspects".miRNAs and their putative roles in the development and progression of Parkinson's disease.Approaches to manipulating microRNAs in neurogenesis.Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration.Genotype and age at Parkinson disease diagnosis.MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression.Preclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's DiseasemiR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models.Advances with microRNAs in Parkinson's disease research.FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF.In Silico Study of miRNA Based Gene Regulation, Involved in Solid Cancer, by the Assistance of Argonaute Protein.Network analysis of human post-mortem microarrays reveals novel genes, microRNAs, and mechanistic scenarios of potential importance in fighting huntington's disease.miRNAs: Key Players in Neurodegenerative Disorders and EpilepsyFrom cellular senescence to age-associated diseases: the miRNA connection.Integrated analysis of microRNAs and their disease related targets in the brain of mice infected with West Nile virus.
P2860
Q21129476-10CCDD41-C30D-4040-BE90-CB022171B5BDQ26786876-A9E22107-1680-4CF1-A57E-8CD9424CCE1FQ26859071-FC30ADA6-E7ED-46AA-9C01-61B1E6047869Q27007056-255D6690-0E13-4859-B4E4-3181BAFFD21EQ27025394-F5D646F4-8375-4D20-B339-77228EEF417EQ27321168-192BE215-7C51-42E8-8E9F-1DFABA0B9C55Q28079707-7ADE8533-9AF1-4C4D-B451-6E581E951DE3Q28084395-AE36D4AB-A637-4B17-86B0-1C11F050CECBQ28271237-48B013A1-5ECB-46C0-BC35-0B4AC9A0CCBBQ33567669-0CE5335C-99D4-4952-9531-305F10036574Q33738316-AA0885CB-5EA5-415F-A330-B60F3F77EF46Q33906476-6FB3C46C-4CAB-4CFE-A806-7B40CC83C512Q34079386-004E32FC-A0A6-4670-B4AD-DCB26B3FB24FQ34197681-E532BC55-94A9-4463-8EF7-B6297EBF6C33Q34828148-17B7593A-D49F-4D96-8008-289C4CD0EA48Q35014097-AC2840FF-E18A-4D30-9950-0B870983D449Q35105770-A5883068-B234-46C5-AFCF-594731C9EFC0Q35126377-E725E0D6-20D2-4CE1-9065-53A044C1C753Q35147342-A2F710D8-36D3-4C8B-A83F-9D6A9B3FC3F1Q35223619-1C5F8D11-7DA8-4561-8743-537E3E50CD6EQ35583229-2A36B008-B623-4276-BC67-7B59B0FC82E7Q36204932-37EC3548-BADF-4DD4-967D-2C0AE3D71C29Q36209324-1863B7BE-044E-46A7-9A44-BA9BFB3EFC22Q36310536-BD5F60BD-A0E0-4171-90D9-38FC118BDE71Q36335261-3C5C3675-31CE-4ECA-B3C3-0D075A4DD383Q36357404-E47F0C58-7770-4C1A-9D84-693293AAE89BQ36518947-2FB83BE2-41B8-41F0-B4BC-E3E50E284019Q36540632-7B5D85E5-9173-47E7-964F-659B86A695E8Q36550804-17A590A7-E765-4F16-A2A6-50A9964FC6A6Q36729049-B1A1DA75-FE7B-4A5E-9159-E339C667081DQ36744745-A9D40E9B-F2B6-4898-A5E8-11072A4EAF54Q36939748-AD97AFF7-1F9F-4D62-BC77-C33EABC57DB9Q37083404-8EF85905-922C-4968-A0BB-278E5EDEFEC8Q37221070-74249A73-996E-4BBD-852C-42C79D9251B4Q37277536-868ACEAD-DD1F-4BBA-8F20-8E153CF4E312Q37324829-B6885480-646D-44E0-831B-C9CF6D6AFBB2Q37453183-2C5DC957-78A9-4E6D-BF44-C221CAD12BDEQ37535111-95806C38-83AF-4336-BF79-AFE690E8AA36Q37581213-5DF587A5-0CA0-4C23-828E-883757A93A58Q37646515-586ECD4F-A04C-44EF-9932-29FAFFE57F61
P2860
MicroRNAs in neurodegenerative diseases and their therapeutic potential.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MicroRNAs in neurodegenerative diseases and their therapeutic potential.
@en
MicroRNAs in neurodegenerative diseases and their therapeutic potential.
@nl
type
label
MicroRNAs in neurodegenerative diseases and their therapeutic potential.
@en
MicroRNAs in neurodegenerative diseases and their therapeutic potential.
@nl
prefLabel
MicroRNAs in neurodegenerative diseases and their therapeutic potential.
@en
MicroRNAs in neurodegenerative diseases and their therapeutic potential.
@nl
P2860
P1476
MicroRNAs in neurodegenerative diseases and their therapeutic potential
@en
P2093
Eunsung Junn
P2860
P304
P356
10.1016/J.PHARMTHERA.2011.10.002
P577
2011-10-08T00:00:00Z